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Abstract
Background: Viral envelope proteins have been proposed to play significant roles in the process of viral infection.
Results: In this study, an envelope protein gene, gC (NCBI GenBank accession no. EU076811), was expressed and
characterized from duck plague virus (DPV), a member of the family herpesviridae. The gene encodes a protein of
432 amino acids with a predicted molecular mass of 45 kDa. Sequence comparisons, multiple alignments and
phylogenetic analysis showed that DPV gC has several features common to other identified herpesvirus gC, and
was genetically close to the gallid herpervirus.
Antibodies raised in rabbits against the pET32a-gC recombinant protein expressed in Escherichia coli BL21 (DE3)
recognized a 45-KDa DPV-specific protein from infected duck embryo fibroblast (DEF) cells. Transcriptional and
expression analysis, using real-time fluorescent quantitative PCR (FQ-PCR) and Western blot detection, revealed that
the transcripts encoding DPV gC and the protein itself appeared late during infection of DEF cells. Immunofluores-
cence localization further demonstrated that the gC protein exhibited substantial cytoplasm fluorescence in DPV-
infected DEF cells.
Conclusions: In this work, the DPV gC protein was successfully expressed in a prokaryotic expression system, and
we presented the basic properties of the DPV gC product for the first time. These properties of the gC protein
provided a prerequisite for further functional analysis of this gene.
Background
Duck plague virus (DPV), or duck enteritis virus (DEV),
is an important pathogen of ducks, which has caused
serious losses in commercial duck production in domes-
tic and wild waterfowl as a result of mortality, condem-
nations, and decreased egg production[1]. DPV is
classified as the subfamily alphaherpesvirinae of the
family herpesviridae based on the report of the Eighth
International Committee on Taxonomy of Viruses
(ICTV), but has not been grouped into any genus[2].
The genome of DPV is composed of a linear, double-
stranded DNA, with 64.3% G+C content which is higher
than any other reported avian herpesvirus in the sub-
family alphaherpesvirinae[3]. To date, more and more
DPV genes have been identified, such as UL24[4-6],
UL31[7,8], UL35[9,10], UL51[11,12], dUTPase[13], and
gE[14] gene. However, the key genes and their functions
remain to be elucidated, especially the viral envelope
protein genes. Viral envelope proteins are particularly
important because of their role in the virus-host rela-
tionship, including recognition, attachment and penetra-
tion of the virus into susceptible cells. In 2006, the DPV
genomic library was successfully constructed in our
laboratory, and one envelope protein gene, gC (NCBI
GenBank accession no. EU076811) was characterized
[15-18], but the basic properties and biological functions
of this envelope protein are not known.
gC is a major component of the virion envelope and is
proved to be a multifunctional protein. gC homologues
of herpes simplex virus type 1 (HSV-1), pseudorabies
virus (PRV), and bovine herpesvirus type 1 (BHV-1), is
the primary attachment protein, interacting with cell
surface heparan sulfate proteoglycans (HSPG), thus
mediating efficient virus attachment to the cells[19-24].
gC of HSV-1, varicella-zoster virus (VZV) and PRV
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case of Marek’s disease virus (MDV), gC is required for
horizontal transmission, together with US2, UL13 in
combination[29]. Furthermore, gC has been demon-
strated to be a critical immune evasion molecule, and
the two glycoproteins, gC and gE, have a synergistic
effect on mediating immune evasion[30,31]. And gC of
H S V - 1a n d- 2 ,B H V - 1 ,P R V ,a n dE q u i n eh e r p e sv i r u s
types 1 and 4 (EHV-1 and -4) has been reported to bind
complement component C3[32-34], thus modulating
complement activation. Although nonessential for virus
infectivity of cultured cells, gC is a highly antigenic gly-
coprotein, of which the importance in eliciting immune
responses has been well documented for many herpes-
viruses[35-39]. However, whether the product of DPV
gC gene shares these functions remains to be
determined.
To begin addressing questions regarding gC properties
or functions, we cloned and expressed the gC gene from
DPV in the prokaryotic expression system, raised anti-
s e r u mt h a tr e c o g n i z e st h eg Cp r o t e i na n dr e v e a l e di t s
temporal transcription course and subcellular localiza-
tion in DPV-infected DEF cells. This work might pro-
vide a foundation for further studies on the function of
DPV gC.
Results
Cloning, prokaryotic expression and antigenicity analysis
of the recombinant protein
D P Vg Cg e n ef r o mt h eg e n o m i cD N Aw a sa m p l i f i e d
and cloned into a T/A cloning vector pMD18-T, gen-
erating a recombinant cloning plasmid pMD18-T/gC
(Figure 1). The recombinant plasmid was confirmed by
DNA sequencing, PCR and restriction digestion (Figure
2a). The gC gene fragment, which was obtained by
digestion of pMD18-T/gC with EcoRI and XhoI, was
ligated into the fusion expression vector pET32a(+)
(Figure 3) and identified by PCR and restriction diges-
tion (Figure 2b). After confirmation, a positive clone
was submitted to DNA sequencing and the result con-
firmed that the gC gene was in frame with the N-term-
inal His6 tag within the pET32a(+) multiple cloning
sites (data not shown). Then this recombinant plasmid,
pET32a-gC, was transformed into Escherichia coli
BL21 (DE3) which, following induction with IPTG,
expressed large quantities of the pET32a-gC recombi-
nant protein (Figure 4a), and this recombinant protein
was purified by gel and electric elution (Figure 4b). In
order to examine the reactivity and specificity of the
recombinant fusion protein, Western blot analysis was
carried out. As shown in Figure 4b, the anti-DPV
serum specifically recognized a 65 kDa band, which
corresponded to the theoretical molecular mass of
pET32a-gC.
Transcriptional analysis of DPV gC gene
FQ-PCRs were used to detect the expression of the DPV gC
gene during viral infection. Total RNA was isolated from
mock-or DPV-infected cells at indicated times, and then
cDNA was synthesized using reverse transcriptase. Aliquots
of cDNA at each time point were used as template for real-
time PCR reactions containing primers either for gC gene
or for b-actin. Table 1 presents data from experiments
where the target (gC) and reference (b-actin) were amplified
in separate wells. The 2
-ΔΔCt method was used to calculate
relative changes in the gene expression determined from
quantitative real-time PCR experiments. As shown in Figure
5 the level of gC mRNA had been increasing since 4 hpi,
peaked between 28 and 36 hpi, and then declined.
Time course expression of DPV gC protein
In this experiment, DEF cells were mock infected or
infected with DPV, and at 4, 16, 32, 48, 60, 72 hpi, cell
suspensions were harvested and lysed in RIPA buffer.
Equal amounts of cell lysates were resolved by SDS-
PAGE, and proteins on the gel were electrophoretically
transferred to PVDF membrane and subjected to Wes-
tern blot analysis with rabbit anti-DPV gC serum. The
result, shown in Figure 6 revealed that a 45 kDa protein
was readily detected as early as 4 hpi and seemed to be
present at increased levels at 48 hpi.
Subcellular localization
The subcellular localization of gC protein was examined
by indirect immunofluorescence staining. At various
times after infection, DEF cells infected with DPV were
fixed with 4% paraformaldehyde, treated with 5% bovine
serum albumin (BSA) to block nonspecific binding and
reacted with the DPV gC antiserum. Specific fluores-
cence became detectable only in the cytoplasm of
infected cells as early as 4 hpi. At later times of infec-
tion, the protein converged at the perinuclear region of
the cytoplasm. And after 60 hr, fluorescence was gently
dispersed (Figure 7).
Discussion
In this study we expand our initial observations, in
which we identified and characterized the DPV gC gene
and found that it has homologues in some herpesviruses
sequenced to date. Analysis of the predicted 432 amino
acid DPV gC protein indicates that it has several fea-
tures common to other herpesvirus glycoproteins. There
is a hydrophobic sequence of about 22 amino acids at
the amino terminus that corresponds to a signal peptide
and a 23-amino-acid hydrophobic sequence near the
carboxy terminus that is predicted to span the mem-
brane of the virus envelope. Amino acid sequence com-
parison revealed that DPV gC gene displayed similarities
of 29.9%, 29.5%, 31.7% to this gene from MeHV-1,
Lian et al. Virology Journal 2010, 7:349
http://www.virologyj.com/content/7/1/349
Page 2 of 11MDV1, MDV2, respectively. Further detailed analysis
showed that it possessed a Marek’s disease glycoprotein
A conserved structural domain between the residues
170 and 425, indicating that the DPV gC and its coun-
terpart in MDV may have similar functions.
As a first step toward the study of the gC protein, rab-
bit polyclonal antiserum specific to this protein were
raised using an Escherichia coli BL21-produced recom-
binant gC fusion protein as antigen. For this purpose
the plasmid pET32a-gC was constructed. When
Figure 1 Schematic diagram of gC gene cloned into the pMD18-T cloning vector.
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expresses the gC gene fragment along with a His6 tag
attached to the N terminus. High levels of the resulting
65 kDa fusion protein were expressed in Escherichia coli
BL21 following induction by IPTG. The induced fusion
protein was purified as described in Methods.
To examine the reactivity and specificity of DPV gC
protein, Western blot experiments were performed. The
result showed that the fusion pET32a-gC protein was
recognized by the rabbit anti-DPV IgG, indicating that
the protein had good immunogenicity. Then the fusion
pET32a-gC protein was used as antigen to produce the
rabbit polyclonal antiserum specific for gC. The fusion
pET32a-gC protein was recognized with the pET32a-gC
antiserum by Western blot and the antiserum specifi-
cally reacted with a protein of approximately 45 kDa
protein in DPV-infected DEF cells. These results indi-
cated that the antiserum had a high level of reactivity
and specificity. Therefore, we used this polyclonal anti-
serum for further experiments to characterize the gC
protein of DPV.
During a productive infection of cultured cells, genes
of herpesvirus have been found to be expressed in a
temporally regulated cascade, in which immediate-early
(IE) genes are expressed first, followed by early (E)
genes and finally by late (L) genes[40]. Late genes are
subdivided into two categories as leaky-late (g1)o r
strict-late (g2). The g1 genes can be suboptimally
expressed in the absence of viral DNA synthesis,
whereas the g2, have a strict requirement for viral DNA
synthesis. gC gene of many herpesviruses has been
identified as a g2 gene, which is highly dependent upon
the IE protein ICP27 during viral infection[41-47]. In
HeLa cells infected with HSV-1 (5 PFU/cell), the tran-
script for the g2 gC was present from 2 to 8 hpi and the
relative increase in gC transcript was detected by 8-h
RNA hybridization[48]. Levine M[49] reported that gC
protein was expressed at high levels within a single HSV
replication cycle of about 10 to 14 h. From our data, the
level of DPV gC mRNA had been increasing since 4 hpi,
with maximal amounts between 28 and 36 hpi and the
maximum gC expression was achieved by 48 hpi. These
results demonstrated that the expression of this gene
occurred at the late stage of infection, which was to
some extent consistent with the results from the pre-
vious observations. In this report, DPV gC mRNA and
protein peak levels were detected much later compared
to HSV-1 gC gene, probably because of the difference in
the cell type and the dose of infection.
Currently, little is known about the subcellular locali-
zation of the herpesviruses gC. To assemble clues to the
function of the gene product, we investigated the sub-
cellular localization of DPV gC in infected cells by indir-
ect immunofluorescence experiments. The presented
results showed that cytoplasm fluorescence first
appeared in DPV-infected cells at 4 hpi. At later times
of infection, the specific fluorescence was localized pre-
dominantly intracellularly in a perinuclear region which
probably corresponds to the rough endoplasmic reticu-
lum and/or Golgi apparatus of the infected cells, in
which viral glycoproteins were synthesized and/or
modificated.
Figure 2 Identification and characterization of pMD18-T/gC and pET32a-gC with restriction enzyme and PCR-based amplification. (a)
Identification of pMD18-T/gC with restriction enzyme and PCR-based amplification. Lanes: 1, pMD18-T/gC digested with EcoRI and XhoI; 2,
product amplified from pMD18-T/gC. M, DNA marker. (b) Characterization of the recombinant plasmid pET32a-gC by restriction digestion and
PCR-based amplification. Lanes: 1, pET32a-gC digested with EcoRI and XhoI; 2, product amplified from pET32a-gC. M, DNA marker, marker III.
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I nt h i sw o r k ,w ec h a r a c t e r i z e dt h eg Cg e n eo fD P V ,
including the prokaryotic expression, antibody prepara-
tion, gene temporal transcription/translation course and
subcellular localization. We found that the expression of
this gene appeared at the late stage of viral infection
and the gC protein showed a pronounced cytoplasmic
staining in infected cells. These properties of the gC
protein provide a foundation for further functional ana-
lysis of this gene.
Figure 3 Construction of the recombinant expression plasmid pET32a-gC.
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Cells and virus
Duck embryo fibroblasts (DEF) were cultured at 37°C
with 5% CO2 in minimal essential medium (MEM) con-
taining 10% fetal bovine serum (FBS) (Hyclone, Logan,
Utah, USA), 100 U/ml penicillin, and 100 μg/ml
streptomycin.
DPV CH virulent strain was obtained from the Avian
Disease Research Center of Sichuan Agricultural Univer-
sity. For infection, DPV of 2.2 × 10
7 TCID50/ml was
employed.
After DPV inoculation, the DEF were incubated in
MEM containing 3% FBS. Usually, the maximum virus
titers could be obtained 72 h postinfection (hpi) when
the cytopathic effect (CPE) was over 75%.
PCR amplification and plasmid construction
Ap a i ro fp r i m e r s( 5 ’-CGGAATTCCAAAACGCCGCA-
CAGATGAC-3’ and 5’-CCCTCGAGGTATTCAAA-
TAATATTGTCTGC-3’) was designed and used to
amplify DPV gC gene from the genomic DNA. The
amplified PCR product was cloned into a T/A cloning
Figure 4 Expression, purification and antigenicity analysis of pET32a-gC recombinant fusion protein. (a) Expression of pET32a-gC
recombinant fusion protein. Lanes: 1, pET32a-gC, non-induced; 2, pET32a-gC, induced by 0.6 mmol/L IPTG; 3, pET32a-gC, induced by 1 mmol/L
IPTG; 4, IPTG-induced inclusion body fraction. (b) Purification and antigenicity analysis of the recombinant fusion protein. Lanes: 1, Purification of
the fusion protein by electric elution; 2, Western blot result of pET32a-gC recombinant fusion protein. M, Protein molecular mass markers.
Table 1 Sample spreadsheet of data analysis using the 2-ΔΔCt method
Time gC b-actin ΔΔCt 2
-ΔΔCt Log
MeanCt,TimeX MeanCt,Time0 MeanCt,TimeX MeanCt,Time0 (2
-ΔΔCt)
1 h 21.3 24.5 10.6 13.7 -0.1 1.071773 0.03
4 h 20.7 24.5 11.3 13.7 -1.4 2.639015 0.42
7 h 19.6 24.5 12.5 13.7 -3.7 12.99603 1.11
10 h 16.5 24.5 12.5 13.7 -6.8 111.4304 2.05
14 h 14.1 24.5 10.7 13.7 -7.4 168.897 2.23
20 h 14.6 24.5 12.4 13.7 -8.6 388.0234 2.59
28 h 11.3 24.5 17.9 13.7 -17.4 172950.5 5.24
36 h 11.9 24.5 18.5 13.7 -17.4 172950.5 5.24
54 h 14.4 24.5 19.8 13.7 -16.2 75281.1 4.88
72 h 18.9 24.5 24 13.7 -15.9 61147.25 4.79
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cloning plasmid pMD18-T/gC (Figure 1). After verified
by PCR, restriction analysis and DNA sequencing
(TaKaRa), the gC gene fragment, which was obtained by
digestion of pMD18-T/gC with EcoRI and XhoI, was
ligated into prokaryotic vector pET32a(+) (Novagen)
(Figure 3), which was digested previously with the same
restriction enzymes. The recombinant plasmid, named
pET32a-gC, was confirmed by PCR, restriction enzyme
digestion and DNA sequencing (TaKaRa).
Prokaryotic expression, protein purification and antibody
preparation
pET32a-gC was transformed into Escherichia coli BL21
(DE3) and the bacteria were induced for 4 h with 0.6
mM IPTG at 37°C to express the fusion protein. The
fusion protein was purified from inclusion bodies by gel
and electric elution. To test the antigenicity of the
recombinant fusion protein, proteins separated by 12%
SDS-PAGE were subsequently subjected to Western blot
analysis with rabbit anti-DPV serum. The purified
recombinant protein was then mixed with an equal
volume of Freund’s complete adjuvant (Sigma) and used
to immunize rabbits by intradermal injection, followed
by two additional intradermal inoculations with Freund’s
incomplete adjuvant once every 7 days and the last
inoculation with the purified recombinant protein. After
the fourth immunization, anti-DPV gC serum was col-
lected. Then, the purified IgG polyclonal antibodies
were obtained by purification using caprylic acid and
ammonium sulfate precipitation and High-Q anion
exchange chromatography.
FQ-PCR
Total RNA was isolated from mock-or DPV-infected cells
at different times (1, 4, 7, 10, 14, 20, 28, 36, 54, 72 hpi)
and was reverse transcribed at 37°C for 120 min using
random primer according to the manufacturer’s instruc-
tions. The real-time PCR assays were performed using an
iCycler iQ™ real-time PCR detection system (Bio-Rad
Lab., Hercules, CA, USA). The primers used for PCR
amplification were as follows: forward primer 5’-GA-
AGGACGGAATGGTGGAAG-3’ and reverse primer
5’-AGCGGGTAACGAGATCTAATATTGA-3’,w h i c h
amplify a 78-base pair (bp) fragment of DPV gC gene,
and for the endogenous control gene b-actin, forward
primer 5’-CCGGGCATCGCTGACA-3’ and reverse pri-
mer 5’-GGATTCATCATACTCCTGCTTGCT-3’.T h e
Figure 5 Transcriptional analysis of DPV gC gene. Total RNA was isolated from the cells at each time point and converted to cDNA. Samples
of cDNA (1 μl) were amplified using real-time quantitative PCR and SYBR green detection. Presented is the fold change in the expression of gC
gene.
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containing 9 μl of POWER High-Capacity cDNA Reverse
T r a n s c r i p t i o nK i t sS Y B RG r e e nP C Rm a s t e rm i x
(Applied Biosystems), 0.5 μl of each primer, 1 μlo f
cDNA template and 9 μl of sterile ultra pure water.
Three replicates of each reaction were performed. The
PCR condition consisted of one cycle of 1 min at 95°C
followed by 40 two-step cycles of 30 sec at 94°C and 30
sec at 60°C. Homogeneity of products from each reaction
was confirmed by melt curve analysis. Analysis of the
real-time PCR data was carried out using the comparative
ΔΔCt method[50]. The fold change in expression of gC
gene relative to the endogenous control gene (b-actin) at
various time points was calculated as Fold change =
Log(2
-ΔΔCt), where ΔΔCt = (Ct, Target-Ct, Reference)Time x-
(Ct, Target-Ct, Reference)Time 0.
Western blot analysis
DEF were either mock infected or infected with DPV of
2.2 × 10
7 TCID50/ml, harvested at various indicated
times (4, 16, 32, 48, 60, 72 hpi), lysed on ice for 30 min
with an equal volume of radioimmunoprecipitation
assay (RIPA) buffer (50 mM Tris-HCl, pH 7.4, 150 mM
NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1%
SDS, and 1 mmol/l phenylmethylsulfonyl fluoride) and
c e n t r i f u g a t e da t1 3 , 0 0 0 × r p mf o r1 5m i na t4 ° C [ 1 3 ] .
Then equivalent amounts of the cell lysates were elec-
trophoresed on 12% SDS-PAGE followed by staining
with Coomassie Brilliant Blue R-250 and simultaneously
electrophoretically transferred to a polyvinylidene fluor-
ide (PVDF) membrane (Bio-Rad Lab., Hercus, CA, USA)
i nat r a n s f e rb u f f e ra t1 2 0Vf o r9 0m i n .F o rW e s t e r n
blot analysis, purified rabbit polyclonal antibodies IgG
was used as the primary antibody at a dilution of 1:50,
followed by horse peroxidase (HRP) conjugated goat
anti-rabbit IgG at a dilution of 1:5000 (KPL Inc.,
Gaithersburg, Maryland, USA) as the secondary
antibody.
Subcellular localization
DEF cells, grown on coverslips in six-well plates, were
mock infected or infected with DPV of 2.2 × 10
7
TCID50/ml and then fixed with 4% paraformaldehyde
for 15 min at room temperature at different times (4,
12, 24, 36, 48, 60 hpi). After blocking in PBS containing
5% bovine serum albumin (BSA) at 37°C for 1 h, the
Figure 6 Expression of gC protein in DPV infected cells. Proteins isolated from mock- (lane 1) or DPV-infected cells at different times (lanes 2
to 7) were analyzed by Western blot analysis with gC antiserum. The arrow shows the expected position for DPV gC (about 45 kDa). The
electrophoresis migration of molecular mass markers is shown on the right.
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bodies IgG (1:100 dilution) specific for recombinant
DPV gC at 4°C overnight, rinsed three times for 10 min
each with PBS and incubated with fluorescein isothio-
cyanate (FITC)-conjugated goat anti-rabbit IgG (Sino-
American Biotechnology Co., Shanghai, China) for 1 h
at 37°C. 4,6-Diamidino-2-phenylindole (DAPI; Sigma)
staining was used to visualize the cell nuclei. Fluorescent
images were viewed and recorded with the Bio-Rad
MRC 1024 imaging system.
Figure 7 Subcellular localization of DPV gC. DEF cells were infected with DPV for 4, 12, 24, 36, 48 or 60 h and the cells were fixed,
permeabilized and stained with anti-DPV gC serum and FITC-conjugated goat anti-rabbit antibody, followed by DAPI. The arrows indicate the
DPV gC FITC fluorescence staining. Mock-infected cells were used as a negative control.
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